(Q54236934)

26 May 2018

title

Comparative hemodynamic effects of amiodarone, sotalol, and d-sotalol. (English)

1 reference

26 May 2018

1 reference

1 reference

N Twidale

1

1 reference

26 May 2018

P Roberts-Thomson

series ordinal

2

1 reference

26 May 2018

R J McRitchie

series ordinal

3

1 reference

26 May 2018

language of work or name

English

0 references

publication date

1 July 1993

1 reference

26 May 2018

published in

American Heart Journal

1 reference

26 May 2018

volume

126

1 reference

26 May 2018

issue

1

1 reference

26 May 2018

page(s)

122-129

1 reference

26 May 2018

A Classification of Antiarrhythmic Actions Reassessed After a Decade of New Drugs

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980018-4

Cardiodepressive effects of antiarrhythmic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980018-4

Comparative hemodynamic effects of procainamide, tocainide, and encainide in severe chronic heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980018-4

Congestive heart failure caused by oral disopyramide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980018-4

Comparative haemodynamic effects of intravenous flecainide in patients with and without heart failure and with and without beta-blocker therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980018-4

Clinical, haemodynamic, and antiarrhythmic effects of long term treatment with amiodarone of patients in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980018-4

Cellular electrophysiological effects of D- and DL-sotalol in guinea-pig sinoatrial node, atrium and ventricle and human atrium: differential tissue sensitivity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980018-4

Effect of amiodarone on ventricular function as measured by gated radionuclide angiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980018-4

Sotalol for refractory sustained ventricular tachycardia and nonfatal cardiac arrest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980018-4

Class III antiarrhythmic action linked with positive inotropy: acute electrophysiological and inotropic effects of amiodarone in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980018-4

Class III Antiarrhythrnic Action Linked with Positive Inotropy: Effects of the d- and 1-Isomer of Sotalol on Isolated Rat Atria at Threshold and Suprathreshold Stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980018-4

Temporal relation between long-lasting aftercontractions and action potentials in cat papillary muscles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980018-4

Hemodynamic effects of intravenous amiodarone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980018-4

Clinical experience with sotalol in patients with drug-refractory ventricular arrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980018-4

Effects of amiodarone on cardiac and coronary hemodynamics and on myocardial metabolism in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980018-4

Hemodynamic effects of intravenous and oral sotalol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980018-4

Cardiovascular Control Mechanisms in the Conscious State

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980018-4

High-performance liquid chromatographic determination of sotalol in plasma. I. Application to the disposition of sotalol enantiomers in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980018-4

Electrophysiologic effects of the levo- and dextrorotatory isomers of sotalol in isolated cardiac muscle and their in vivo pharmacokinetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980018-4

Analysis of amiodarone and desethylamiodarone in serum and tears by reversed-phase high-performance liquid chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980018-4

Some statistical methods useful in circulation research.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980018-4

Amiodarone: electrophysiologic actions, pharmacokinetics and clinical effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980018-4

Pharmacokinetics of amiodarone after intravenous and oral administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980018-4

Electrophysiologic and antiarrhythmic effects of sotalol in patients with life-threatening ventricular tachyarrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980018-4

Sotalol prolongation of the QTc interval in hypertensive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980018-4

Hemodynamic effects of d-sotalol in acute ischemic heart failure in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980018-4

Electrophysiologic effects of d-sotalol in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980018-4

Usefulness and limitations of the rate of rise of intraventricular pressure (dp-dt) in the evaluation of myocardial contractility in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980018-4

Effects of changes in preload, afterload and inotropic state on ejection and isovolumic phase measures of contractility in the conscious dog

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980018-4

Steady-state effects of preload and afterload on isovolumic indices of contractility in autonomically blocked dogs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980018-4

Extent of regulation of the heart's contractile state in the conscious dog by alteration in the frequency of contraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980018-4

Hemodynamic effects and tolerability of intravenous amiodarone in patients with impaired left ventricular function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980018-4

Effects of amiodarone and L8040, novel antianginal and antiarrhythmic drugs, on cardiac and coronary haemodynamics and on cardiac intracellular potentials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980018-4

Acute electrophysiologic and blood pressure effects of amiodarone and its solvent in the dog

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980018-4

A randomized hemodynamic comparison of intravenous amiodarone with and without Tween 80.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980018-4

Clinical electrophysiology of intravenous sotalol, a beta-blocking drug with class III antiarrhythmic properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980018-4

Electrophysiologic testing in assessment of therapy with sotalol for sustained ventricular tachycardia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980018-4

Electrophysiologic effects of intravenous and oral sotalol for sustained ventricular tachycardia secondary to coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980018-4

A mechanism of D-(+)-sotalol effects on heart rate not related to beta-adrenoceptor antagonism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980018-4

Prevention of ventricular fibrillation by dextrorotatory sotalol in a conscious canine model of sudden coronary death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980018-4

Effects of the New Class-III Antiarrhythmic Drug D-Sotalol on Contractile Function of Postischemic Myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980018-4

Intravenous sotalol for the treatment of atrial fibrillation and flutter after cardiopulmonary bypass. Comparison with disopyramide and digoxin in a randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980018-4

Important differences between short- and long-term hemodynamic effects of amiodarone in patients with chronic ischemic heart disease at rest and during ischemia-induced left ventricular dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980018-4

Antiarrhythmic drug effects on left ventricular performance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980018-4

The hemodynamic effects of sotalol and quinidine: analysis by use of rest and exercise gated radionuclide angiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980018-4

10.1016/S0002-8703(07)80018-4

7 January 2021

Identifiers

DOI

1 reference

26 May 2018

1 reference

26 May 2018